

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle exocytosis (GO:0016079) | 5.67561810 |
| 2 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.43580613 |
| 3 | vocalization behavior (GO:0071625) | 5.34259478 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.31385625 |
| 5 | neuron cell-cell adhesion (GO:0007158) | 5.26612718 |
| 6 | protein localization to synapse (GO:0035418) | 5.25930177 |
| 7 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 5.17488339 |
| 8 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.14806362 |
| 9 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.09036017 |
| 10 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.03319842 |
| 11 | glutamate secretion (GO:0014047) | 4.99639845 |
| 12 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.97877571 |
| 13 | neuronal action potential propagation (GO:0019227) | 4.91012756 |
| 14 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.85053255 |
| 15 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.80886913 |
| 16 | glutamate receptor signaling pathway (GO:0007215) | 4.64994939 |
| 17 | presynaptic membrane organization (GO:0097090) | 4.64196592 |
| 18 | presynaptic membrane assembly (GO:0097105) | 4.63542386 |
| 19 | neuron-neuron synaptic transmission (GO:0007270) | 4.58407800 |
| 20 | regulation of synaptic vesicle transport (GO:1902803) | 4.57402518 |
| 21 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.56466657 |
| 22 | gamma-aminobutyric acid transport (GO:0015812) | 4.52136661 |
| 23 | synaptic transmission, glutamatergic (GO:0035249) | 4.46984664 |
| 24 | postsynaptic membrane organization (GO:0001941) | 4.45411755 |
| 25 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.35952779 |
| 26 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 4.33829130 |
| 27 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.29536288 |
| 28 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.23916755 |
| 29 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 4.23603345 |
| 30 | ATP hydrolysis coupled proton transport (GO:0015991) | 4.23603345 |
| 31 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.21056138 |
| 32 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.15663775 |
| 33 | neuron recognition (GO:0008038) | 4.14934104 |
| 34 | cellular ketone body metabolic process (GO:0046950) | 4.09915702 |
| 35 | response to histamine (GO:0034776) | 4.09005012 |
| 36 | regulation of postsynaptic membrane potential (GO:0060078) | 4.06524163 |
| 37 | synaptic vesicle endocytosis (GO:0048488) | 4.04883970 |
| 38 | neurotransmitter secretion (GO:0007269) | 3.94675865 |
| 39 | ATP synthesis coupled proton transport (GO:0015986) | 3.94503973 |
| 40 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.94503973 |
| 41 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.90921816 |
| 42 | transferrin transport (GO:0033572) | 3.90906393 |
| 43 | insulin secretion (GO:0030073) | 3.86399370 |
| 44 | axonal fasciculation (GO:0007413) | 3.85843339 |
| 45 | dendritic spine morphogenesis (GO:0060997) | 3.82274198 |
| 46 | response to pheromone (GO:0019236) | 3.74780908 |
| 47 | alanine transport (GO:0032328) | 3.74477729 |
| 48 | positive regulation of synapse maturation (GO:0090129) | 3.74003589 |
| 49 | positive regulation of synapse assembly (GO:0051965) | 3.69689946 |
| 50 | regulation of glutamate secretion (GO:0014048) | 3.69504663 |
| 51 | long-term synaptic potentiation (GO:0060291) | 3.67264183 |
| 52 | cerebellar granule cell differentiation (GO:0021707) | 3.66401540 |
| 53 | ferric iron transport (GO:0015682) | 3.64222868 |
| 54 | trivalent inorganic cation transport (GO:0072512) | 3.64222868 |
| 55 | inositol phosphate catabolic process (GO:0071545) | 3.63690336 |
| 56 | ketone body metabolic process (GO:1902224) | 3.60333771 |
| 57 | endocrine pancreas development (GO:0031018) | 3.60315721 |
| 58 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.58360377 |
| 59 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.56746380 |
| 60 | membrane hyperpolarization (GO:0060081) | 3.55455544 |
| 61 | cochlea development (GO:0090102) | 3.54815968 |
| 62 | chaperone-mediated protein transport (GO:0072321) | 3.53669489 |
| 63 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.51514262 |
| 64 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.50092022 |
| 65 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.49803801 |
| 66 | mechanosensory behavior (GO:0007638) | 3.49624664 |
| 67 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.46218834 |
| 68 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.45751118 |
| 69 | synaptic vesicle maturation (GO:0016188) | 3.45557028 |
| 70 | positive regulation of membrane potential (GO:0045838) | 3.43646292 |
| 71 | positive regulation of neurotransmitter transport (GO:0051590) | 3.42926149 |
| 72 | inositol phosphate dephosphorylation (GO:0046855) | 3.40731808 |
| 73 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.40731808 |
| 74 | neurotransmitter transport (GO:0006836) | 3.38467047 |
| 75 | regulation of neurotransmitter secretion (GO:0046928) | 3.34854983 |
| 76 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.33743230 |
| 77 | membrane depolarization (GO:0051899) | 3.32730656 |
| 78 | righting reflex (GO:0060013) | 3.31694844 |
| 79 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.31236576 |
| 80 | behavioral defense response (GO:0002209) | 3.30902323 |
| 81 | behavioral fear response (GO:0001662) | 3.30902323 |
| 82 | positive regulation of insulin secretion (GO:0032024) | 3.29022208 |
| 83 | regulation of synaptic plasticity (GO:0048167) | 3.26100914 |
| 84 | female mating behavior (GO:0060180) | 3.24916059 |
| 85 | regulation of vesicle fusion (GO:0031338) | 3.21872277 |
| 86 | auditory behavior (GO:0031223) | 3.21275930 |
| 87 | protein localization to cilium (GO:0061512) | 3.18811285 |
| 88 | long-term memory (GO:0007616) | 3.15681188 |
| 89 | locomotory exploration behavior (GO:0035641) | 3.14500813 |
| 90 | establishment of synaptic vesicle localization (GO:0097480) | 3.14126968 |
| 91 | synaptic vesicle transport (GO:0048489) | 3.14126968 |
| 92 | potassium ion homeostasis (GO:0055075) | 3.12474228 |
| 93 | regulation of neurotransmitter transport (GO:0051588) | 3.11492806 |
| 94 | exploration behavior (GO:0035640) | 3.10790657 |
| 95 | fear response (GO:0042596) | 3.09965374 |
| 96 | positive regulation of amino acid transport (GO:0051957) | 3.08464223 |
| 97 | striatum development (GO:0021756) | 3.07473307 |
| 98 | synaptic transmission (GO:0007268) | 3.05253037 |
| 99 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.04268282 |
| 100 | negative regulation of amino acid transport (GO:0051956) | 3.04238034 |
| 101 | glycerophospholipid catabolic process (GO:0046475) | 3.03808724 |
| 102 | regulation of neurotransmitter levels (GO:0001505) | 3.03311483 |
| 103 | innervation (GO:0060384) | 3.01758883 |
| 104 | phagosome maturation (GO:0090382) | 3.01684080 |
| 105 | behavioral response to cocaine (GO:0048148) | 3.01276589 |
| 106 | detection of calcium ion (GO:0005513) | 3.00899821 |
| 107 | regulation of glucokinase activity (GO:0033131) | 3.00860684 |
| 108 | regulation of hexokinase activity (GO:1903299) | 3.00860684 |
| 109 | polyol catabolic process (GO:0046174) | 2.99651986 |
| 110 | positive regulation of peptide hormone secretion (GO:0090277) | 2.99535919 |
| 111 | neuromuscular process controlling posture (GO:0050884) | 2.99493830 |
| 112 | respiratory electron transport chain (GO:0022904) | 2.98245288 |
| 113 | long term synaptic depression (GO:0060292) | 2.97530981 |
| 114 | response to dietary excess (GO:0002021) | 2.95743856 |
| 115 | proline transport (GO:0015824) | 2.95404738 |
| 116 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.95234112 |
| 117 | startle response (GO:0001964) | 2.95097619 |
| 118 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.95086884 |
| 119 | response to auditory stimulus (GO:0010996) | 2.94787149 |
| 120 | positive regulation of peptide secretion (GO:0002793) | 2.93998958 |
| 121 | regulation of synapse maturation (GO:0090128) | 2.93444584 |
| 122 | regulation of synapse assembly (GO:0051963) | 2.93046244 |
| 123 | electron transport chain (GO:0022900) | 2.92916431 |
| 124 | epithelial cell fate commitment (GO:0072148) | 2.92269083 |
| 125 | transmission of nerve impulse (GO:0019226) | 2.92120046 |
| 126 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.91869408 |
| 127 | positive regulation of synaptic transmission (GO:0050806) | 2.91359635 |
| 128 | synapse assembly (GO:0007416) | 2.90311035 |
| 129 | regulation of feeding behavior (GO:0060259) | 2.90011559 |
| 130 | membrane depolarization during action potential (GO:0086010) | 2.85045279 |
| 131 | prepulse inhibition (GO:0060134) | 2.84496582 |
| 132 | regulation of energy homeostasis (GO:2000505) | 2.83923770 |
| 133 | regulation of neurotransmitter uptake (GO:0051580) | 2.83276012 |
| 134 | reflex (GO:0060004) | 2.79971403 |
| 135 | sphingomyelin metabolic process (GO:0006684) | 2.78989162 |
| 136 | calcium ion import (GO:0070509) | 2.77135804 |
| 137 | chemosensory behavior (GO:0007635) | 2.71507185 |
| 138 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.70130863 |
| 139 | regulation of insulin secretion (GO:0050796) | 2.69835143 |
| 140 | atrial cardiac muscle cell action potential (GO:0086014) | 2.68317755 |
| 141 | peptide hormone secretion (GO:0030072) | 2.67292991 |
| 142 | protein complex biogenesis (GO:0070271) | 2.65831291 |
| 143 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.65643197 |
| 144 | cellular potassium ion homeostasis (GO:0030007) | 2.64680584 |
| 145 | respiratory chain complex IV assembly (GO:0008535) | 2.62521789 |
| 146 | signal release (GO:0023061) | 2.60685532 |
| 147 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.60625853 |
| 148 | nitric oxide mediated signal transduction (GO:0007263) | 2.58382893 |
| 149 | cellular potassium ion transport (GO:0071804) | 2.57343243 |
| 150 | potassium ion transmembrane transport (GO:0071805) | 2.57343243 |
| 151 | peptide secretion (GO:0002790) | 2.56772919 |
| 152 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.56605008 |
| 153 | regulation of respiratory system process (GO:0044065) | 2.56004246 |
| 154 | positive regulation of glycolytic process (GO:0045821) | 2.54911175 |
| 155 | brain morphogenesis (GO:0048854) | 2.52293604 |
| 156 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.50327086 |
| 157 | regulation of peptide hormone secretion (GO:0090276) | 2.49624605 |
| 158 | cytochrome complex assembly (GO:0017004) | 2.49187189 |
| 159 | potassium ion transport (GO:0006813) | 2.48335033 |
| 160 | positive regulation of meiosis (GO:0045836) | 2.46761038 |
| 161 | neuronal action potential (GO:0019228) | 2.45403532 |
| 162 | regulation of peptide secretion (GO:0002791) | 2.45361463 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.78433082 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.10755936 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.57731954 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.29627194 |
| 5 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.19364314 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.15360686 |
| 7 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.83218736 |
| 8 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.73425827 |
| 9 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.73384499 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.70426446 |
| 11 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.70426446 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.65963139 |
| 13 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.64823549 |
| 14 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.60423103 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.55112917 |
| 16 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.54754134 |
| 17 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.41209044 |
| 18 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.40073310 |
| 19 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.35875897 |
| 20 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.32483490 |
| 21 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.32247087 |
| 22 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.28971140 |
| 23 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.20540037 |
| 24 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.19041883 |
| 25 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.18472498 |
| 26 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.14920684 |
| 27 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.13924148 |
| 28 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.13813332 |
| 29 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.10629044 |
| 30 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.09630137 |
| 31 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.09173604 |
| 32 | * VDR_22108803_ChIP-Seq_LS180_Human | 2.06885383 |
| 33 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.00938934 |
| 34 | FUS_26573619_Chip-Seq_HEK293_Human | 1.96605845 |
| 35 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.90705502 |
| 36 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.86167681 |
| 37 | P300_19829295_ChIP-Seq_ESCs_Human | 1.85142093 |
| 38 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.77432622 |
| 39 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.75107148 |
| 40 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.74422155 |
| 41 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.74280141 |
| 42 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.69106618 |
| 43 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.61084851 |
| 44 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.61069141 |
| 45 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.59903363 |
| 46 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.57447845 |
| 47 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.54472266 |
| 48 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.52563375 |
| 49 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.48256519 |
| 50 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.47370771 |
| 51 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.45940205 |
| 52 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.45516777 |
| 53 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.44892319 |
| 54 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.44242529 |
| 55 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.44152846 |
| 56 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.43459302 |
| 57 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.41874214 |
| 58 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.39605749 |
| 59 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.38187663 |
| 60 | AR_25329375_ChIP-Seq_VCAP_Human | 1.37607650 |
| 61 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.36829520 |
| 62 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.36444329 |
| 63 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.35677742 |
| 64 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.33494214 |
| 65 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.33371589 |
| 66 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.32256511 |
| 67 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.27084535 |
| 68 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26716711 |
| 69 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25597269 |
| 70 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.25100857 |
| 71 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.24919235 |
| 72 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.19378256 |
| 73 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.18800415 |
| 74 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.17787157 |
| 75 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.16589861 |
| 76 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.14724789 |
| 77 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.14594050 |
| 78 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.13679642 |
| 79 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.12801564 |
| 80 | STAT3_23295773_ChIP-Seq_U87_Human | 1.12522462 |
| 81 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.12287544 |
| 82 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.11772622 |
| 83 | JUN_21703547_ChIP-Seq_K562_Human | 1.10871186 |
| 84 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.10693115 |
| 85 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.10645956 |
| 86 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.10378970 |
| 87 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.09793648 |
| 88 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.09793648 |
| 89 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.09058574 |
| 90 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.08876249 |
| 91 | TCF4_23295773_ChIP-Seq_U87_Human | 1.07976927 |
| 92 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.06911186 |
| 93 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.06846755 |
| 94 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.06198896 |
| 95 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.04979686 |
| 96 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.04667053 |
| 97 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.04461959 |
| 98 | TP53_16413492_ChIP-PET_HCT116_Human | 1.04100809 |
| 99 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.03690285 |
| 100 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.03278163 |
| 101 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.02795142 |
| 102 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.02462533 |
| 103 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.01769351 |
| 104 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.01009227 |
| 105 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.00540301 |
| 106 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.00475971 |
| 107 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.00391319 |
| 108 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.00195191 |
| 109 | EWS_26573619_Chip-Seq_HEK293_Human | 0.99863342 |
| 110 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.99120893 |
| 111 | AR_19668381_ChIP-Seq_PC3_Human | 0.98863944 |
| 112 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98826853 |
| 113 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.98033407 |
| 114 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.97821577 |
| 115 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.97432114 |
| 116 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.97074135 |
| 117 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.96987599 |
| 118 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.93855034 |
| 119 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.93855034 |
| 120 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.93009598 |
| 121 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91424181 |
| 122 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.89503410 |
| 123 | KDM2B_26808549_Chip-Seq_REH_Human | 0.88941400 |
| 124 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.88446983 |
| 125 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88446983 |
| 126 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.87060492 |
| 127 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.86610159 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 6.13071916 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.94180343 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.88448886 |
| 4 | MP0009745_abnormal_behavioral_response | 3.50179918 |
| 5 | MP0001968_abnormal_touch/_nociception | 3.27006449 |
| 6 | MP0009046_muscle_twitch | 3.25644697 |
| 7 | MP0002064_seizures | 3.25512862 |
| 8 | MP0002063_abnormal_learning/memory/cond | 3.21569019 |
| 9 | MP0002736_abnormal_nociception_after | 3.06007455 |
| 10 | MP0004270_analgesia | 2.90562716 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.79709087 |
| 12 | MP0002272_abnormal_nervous_system | 2.77928797 |
| 13 | MP0001501_abnormal_sleep_pattern | 2.63266101 |
| 14 | MP0002735_abnormal_chemical_nociception | 2.46032328 |
| 15 | MP0003787_abnormal_imprinting | 2.41040622 |
| 16 | MP0005645_abnormal_hypothalamus_physiol | 2.38856942 |
| 17 | MP0006276_abnormal_autonomic_nervous | 2.37224419 |
| 18 | MP0003122_maternal_imprinting | 2.35982430 |
| 19 | MP0001440_abnormal_grooming_behavior | 2.32861082 |
| 20 | MP0002734_abnormal_mechanical_nocicepti | 2.21139816 |
| 21 | MP0005379_endocrine/exocrine_gland_phen | 2.19587323 |
| 22 | MP0001529_abnormal_vocalization | 2.17357936 |
| 23 | MP0002067_abnormal_sensory_capabilities | 2.13216259 |
| 24 | MP0010234_abnormal_vibrissa_follicle | 2.12526607 |
| 25 | MP0001486_abnormal_startle_reflex | 2.09427468 |
| 26 | MP0002876_abnormal_thyroid_physiology | 1.98173139 |
| 27 | MP0002837_dystrophic_cardiac_calcinosis | 1.93863312 |
| 28 | MP0002733_abnormal_thermal_nociception | 1.93827457 |
| 29 | MP0003879_abnormal_hair_cell | 1.86436045 |
| 30 | MP0001986_abnormal_taste_sensitivity | 1.85664023 |
| 31 | MP0001970_abnormal_pain_threshold | 1.85413492 |
| 32 | MP0001944_abnormal_pancreas_morphology | 1.85098455 |
| 33 | MP0001984_abnormal_olfaction | 1.84763817 |
| 34 | MP0005646_abnormal_pituitary_gland | 1.81313622 |
| 35 | MP0002184_abnormal_innervation | 1.80661911 |
| 36 | MP0005423_abnormal_somatic_nervous | 1.74282695 |
| 37 | MP0009780_abnormal_chondrocyte_physiolo | 1.74256091 |
| 38 | MP0000778_abnormal_nervous_system | 1.72268807 |
| 39 | MP0003195_calcinosis | 1.71676428 |
| 40 | MP0002693_abnormal_pancreas_physiology | 1.68341422 |
| 41 | MP0002557_abnormal_social/conspecific_i | 1.67103238 |
| 42 | MP0005386_behavior/neurological_phenoty | 1.62245275 |
| 43 | MP0004924_abnormal_behavior | 1.62245275 |
| 44 | MP0003283_abnormal_digestive_organ | 1.60802070 |
| 45 | MP0001188_hyperpigmentation | 1.59566817 |
| 46 | MP0003329_amyloid_beta_deposits | 1.51621017 |
| 47 | MP0003123_paternal_imprinting | 1.51379299 |
| 48 | MP0002822_catalepsy | 1.50782349 |
| 49 | MP0001905_abnormal_dopamine_level | 1.49836234 |
| 50 | MP0000569_abnormal_digit_pigmentation | 1.42743415 |
| 51 | MP0004043_abnormal_pH_regulation | 1.42193735 |
| 52 | MP0001502_abnormal_circadian_rhythm | 1.35455709 |
| 53 | MP0002066_abnormal_motor_capabilities/c | 1.31569450 |
| 54 | MP0004811_abnormal_neuron_physiology | 1.30972112 |
| 55 | MP0008877_abnormal_DNA_methylation | 1.30533724 |
| 56 | MP0004142_abnormal_muscle_tone | 1.29461490 |
| 57 | MP0008569_lethality_at_weaning | 1.29094417 |
| 58 | MP0010386_abnormal_urinary_bladder | 1.27064834 |
| 59 | MP0005551_abnormal_eye_electrophysiolog | 1.25338111 |
| 60 | MP0002909_abnormal_adrenal_gland | 1.24019175 |
| 61 | MP0000955_abnormal_spinal_cord | 1.23805201 |
| 62 | MP0003121_genomic_imprinting | 1.22852259 |
| 63 | MP0002882_abnormal_neuron_morphology | 1.22640635 |
| 64 | MP0002928_abnormal_bile_duct | 1.22019824 |
| 65 | MP0004145_abnormal_muscle_electrophysio | 1.21836447 |
| 66 | MP0000751_myopathy | 1.20714481 |
| 67 | MP0004742_abnormal_vestibular_system | 1.17882492 |
| 68 | MP0002638_abnormal_pupillary_reflex | 1.17189524 |
| 69 | MP0004147_increased_porphyrin_level | 1.15669504 |
| 70 | MP0002078_abnormal_glucose_homeostasis | 1.15223631 |
| 71 | MP0005253_abnormal_eye_physiology | 1.13032299 |
| 72 | MP0000631_abnormal_neuroendocrine_gland | 1.08016144 |
| 73 | MP0002139_abnormal_hepatobiliary_system | 1.07943398 |
| 74 | MP0005084_abnormal_gallbladder_morpholo | 1.06186585 |
| 75 | MP0005448_abnormal_energy_balance | 1.05608351 |
| 76 | MP0010329_abnormal_lipoprotein_level | 1.00400315 |
| 77 | MP0004215_abnormal_myocardial_fiber | 1.00283439 |
| 78 | MP0004019_abnormal_vitamin_homeostasis | 0.99411199 |
| 79 | MP0002152_abnormal_brain_morphology | 0.98323675 |
| 80 | MP0001756_abnormal_urination | 0.96156598 |
| 81 | MP0001963_abnormal_hearing_physiology | 0.95319820 |
| 82 | MP0000639_abnormal_adrenal_gland | 0.95153374 |
| 83 | MP0005394_taste/olfaction_phenotype | 0.93723288 |
| 84 | MP0005499_abnormal_olfactory_system | 0.93723288 |
| 85 | MP0008874_decreased_physiological_sensi | 0.91473208 |
| 86 | MP0008961_abnormal_basal_metabolism | 0.90854591 |
| 87 | MP0002254_reproductive_system_inflammat | 0.90801297 |
| 88 | MP0008872_abnormal_physiological_respon | 0.89380664 |
| 89 | MP0003633_abnormal_nervous_system | 0.89327085 |
| 90 | MP0002938_white_spotting | 0.87537867 |
| 91 | MP0004085_abnormal_heartbeat | 0.86702187 |
| 92 | MP0000516_abnormal_urinary_system | 0.86510400 |
| 93 | MP0005367_renal/urinary_system_phenotyp | 0.86510400 |
| 94 | MP0004858_abnormal_nervous_system | 0.86220904 |
| 95 | MP0005220_abnormal_exocrine_pancreas | 0.85496464 |
| 96 | MP0003953_abnormal_hormone_level | 0.85077981 |
| 97 | MP0002069_abnormal_eating/drinking_beha | 0.84715253 |
| 98 | MP0003631_nervous_system_phenotype | 0.84008211 |
| 99 | MP0002752_abnormal_somatic_nervous | 0.83910127 |
| 100 | MP0005174_abnormal_tail_pigmentation | 0.83048385 |
| 101 | MP0005332_abnormal_amino_acid | 0.82726796 |
| 102 | MP0000003_abnormal_adipose_tissue | 0.82666456 |
| 103 | MP0001765_abnormal_ion_homeostasis | 0.79708811 |
| 104 | MP0000427_abnormal_hair_cycle | 0.78293654 |
| 105 | MP0000013_abnormal_adipose_tissue | 0.78247376 |
| 106 | MP0005248_abnormal_Harderian_gland | 0.78029220 |
| 107 | MP0004233_abnormal_muscle_weight | 0.76536859 |
| 108 | MP0004484_altered_response_of | 0.76028051 |
| 109 | MP0002229_neurodegeneration | 0.75826996 |
| 110 | MP0001346_abnormal_lacrimal_gland | 0.74844841 |
| 111 | MP0000026_abnormal_inner_ear | 0.74139378 |
| 112 | MP0000604_amyloidosis | 0.72481202 |
| 113 | MP0001727_abnormal_embryo_implantation | 0.70664935 |
| 114 | MP0004885_abnormal_endolymph | 0.69996677 |
| 115 | MP0001664_abnormal_digestion | 0.68632924 |
| 116 | MP0001485_abnormal_pinna_reflex | 0.68416529 |
| 117 | MP0005535_abnormal_body_temperature | 0.67628035 |
| 118 | MP0006072_abnormal_retinal_apoptosis | 0.63579921 |
| 119 | MP0005623_abnormal_meninges_morphology | 0.61603955 |
| 120 | MP0006292_abnormal_olfactory_placode | 0.59870775 |
| 121 | MP0005171_absent_coat_pigmentation | 0.59471413 |
| 122 | MP0004510_myositis | 0.59313462 |
| 123 | MP0003632_abnormal_nervous_system | 0.55742818 |
| 124 | MP0003137_abnormal_impulse_conducting | 0.55363599 |
| 125 | MP0002163_abnormal_gland_morphology | 0.52886347 |
| 126 | * MP0001943_abnormal_respiration | 0.52685110 |
| 127 | MP0003646_muscle_fatigue | 0.51520540 |
| 128 | MP0002082_postnatal_lethality | 0.49283714 |
| 129 | MP0010770_preweaning_lethality | 0.49283714 |
| 130 | MP0001348_abnormal_lacrimal_gland | 0.48695101 |
| 131 | MP0002102_abnormal_ear_morphology | 0.48323881 |
| 132 | MP0005310_abnormal_salivary_gland | 0.47384430 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.30274100 |
| 2 | Epileptic encephalopathy (HP:0200134) | 5.95014266 |
| 3 | Atonic seizures (HP:0010819) | 5.79544367 |
| 4 | Focal seizures (HP:0007359) | 5.60808902 |
| 5 | Hyperventilation (HP:0002883) | 5.03167040 |
| 6 | Absence seizures (HP:0002121) | 4.86600963 |
| 7 | Febrile seizures (HP:0002373) | 4.85525068 |
| 8 | Dialeptic seizures (HP:0011146) | 4.45654395 |
| 9 | Myokymia (HP:0002411) | 4.26265517 |
| 10 | Ketoacidosis (HP:0001993) | 4.22885621 |
| 11 | Visual hallucinations (HP:0002367) | 4.16683256 |
| 12 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.90257943 |
| 13 | Acute necrotizing encephalopathy (HP:0006965) | 3.75892376 |
| 14 | Generalized tonic-clonic seizures (HP:0002069) | 3.74452535 |
| 15 | Large for gestational age (HP:0001520) | 3.64282679 |
| 16 | Hypoglycemic seizures (HP:0002173) | 3.63547517 |
| 17 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.51390639 |
| 18 | Hypoglycemic coma (HP:0001325) | 3.49166332 |
| 19 | Amblyopia (HP:0000646) | 3.43618380 |
| 20 | Hypothermia (HP:0002045) | 3.40042867 |
| 21 | Abnormal hair whorl (HP:0010721) | 3.38632794 |
| 22 | Progressive macrocephaly (HP:0004481) | 3.38570762 |
| 23 | Mitochondrial inheritance (HP:0001427) | 3.30273998 |
| 24 | Limb dystonia (HP:0002451) | 3.29887399 |
| 25 | Broad-based gait (HP:0002136) | 3.25166428 |
| 26 | Hyperglycemia (HP:0003074) | 3.23756739 |
| 27 | Progressive cerebellar ataxia (HP:0002073) | 3.22432514 |
| 28 | Intestinal atresia (HP:0011100) | 3.13083978 |
| 29 | Gait imbalance (HP:0002141) | 3.01102540 |
| 30 | Polyphagia (HP:0002591) | 2.89971000 |
| 31 | Epileptiform EEG discharges (HP:0011182) | 2.85625493 |
| 32 | Acute encephalopathy (HP:0006846) | 2.84021574 |
| 33 | Medial flaring of the eyebrow (HP:0010747) | 2.81984511 |
| 34 | Abnormal eating behavior (HP:0100738) | 2.79978579 |
| 35 | Congenital primary aphakia (HP:0007707) | 2.79785173 |
| 36 | Late onset (HP:0003584) | 2.77588139 |
| 37 | Anxiety (HP:0000739) | 2.76206050 |
| 38 | Increased CSF lactate (HP:0002490) | 2.75240881 |
| 39 | Ketosis (HP:0001946) | 2.73762479 |
| 40 | Gaze-evoked nystagmus (HP:0000640) | 2.73136842 |
| 41 | Abnormality of glycolysis (HP:0004366) | 2.68006873 |
| 42 | Increased serum pyruvate (HP:0003542) | 2.68006873 |
| 43 | Abnormality of the labia minora (HP:0012880) | 2.67647263 |
| 44 | Excessive salivation (HP:0003781) | 2.65633514 |
| 45 | Drooling (HP:0002307) | 2.65633514 |
| 46 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.64290924 |
| 47 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.64290924 |
| 48 | Congenital stationary night blindness (HP:0007642) | 2.63193869 |
| 49 | Nephrogenic diabetes insipidus (HP:0009806) | 2.61889946 |
| 50 | Intention tremor (HP:0002080) | 2.60068329 |
| 51 | Pheochromocytoma (HP:0002666) | 2.59355974 |
| 52 | EEG with generalized epileptiform discharges (HP:0011198) | 2.57428530 |
| 53 | Hepatocellular necrosis (HP:0001404) | 2.56912914 |
| 54 | Inability to walk (HP:0002540) | 2.56876665 |
| 55 | Muscular hypotonia of the trunk (HP:0008936) | 2.56604724 |
| 56 | Agitation (HP:0000713) | 2.56282807 |
| 57 | Poor suck (HP:0002033) | 2.55688485 |
| 58 | Truncal ataxia (HP:0002078) | 2.55288113 |
| 59 | Protruding tongue (HP:0010808) | 2.53576611 |
| 60 | Neuroendocrine neoplasm (HP:0100634) | 2.51758420 |
| 61 | Progressive inability to walk (HP:0002505) | 2.51501153 |
| 62 | Hydroureter (HP:0000072) | 2.48933341 |
| 63 | Poor eye contact (HP:0000817) | 2.47148740 |
| 64 | Hypoventilation (HP:0002791) | 2.46073307 |
| 65 | Methylmalonic acidemia (HP:0002912) | 2.43998540 |
| 66 | Glycosuria (HP:0003076) | 2.43356301 |
| 67 | Abnormality of urine glucose concentration (HP:0011016) | 2.43356301 |
| 68 | Failure to thrive in infancy (HP:0001531) | 2.39704564 |
| 69 | Abnormality of vitamin B metabolism (HP:0004340) | 2.39593258 |
| 70 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.37231359 |
| 71 | Hyperthyroidism (HP:0000836) | 2.36287518 |
| 72 | Optic disc pallor (HP:0000543) | 2.33865007 |
| 73 | Type II lissencephaly (HP:0007260) | 2.33585666 |
| 74 | Hypsarrhythmia (HP:0002521) | 2.32287699 |
| 75 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.32167833 |
| 76 | Dysmetria (HP:0001310) | 2.31938813 |
| 77 | Postural tremor (HP:0002174) | 2.29980701 |
| 78 | Oligomenorrhea (HP:0000876) | 2.26307978 |
| 79 | Double outlet right ventricle (HP:0001719) | 2.26118594 |
| 80 | Congenital malformation of the right heart (HP:0011723) | 2.26118594 |
| 81 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.25978230 |
| 82 | Supranuclear gaze palsy (HP:0000605) | 2.24205151 |
| 83 | Specific learning disability (HP:0001328) | 2.23545959 |
| 84 | Hypomagnesemia (HP:0002917) | 2.23510306 |
| 85 | Depression (HP:0000716) | 2.23471079 |
| 86 | Abnormality of binocular vision (HP:0011514) | 2.23009795 |
| 87 | Diplopia (HP:0000651) | 2.23009795 |
| 88 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.22450503 |
| 89 | Nephronophthisis (HP:0000090) | 2.22195410 |
| 90 | Narrow nasal bridge (HP:0000446) | 2.21793200 |
| 91 | Impaired social interactions (HP:0000735) | 2.19490694 |
| 92 | Abnormal social behavior (HP:0012433) | 2.19490694 |
| 93 | Dysdiadochokinesis (HP:0002075) | 2.19170813 |
| 94 | Enlarged penis (HP:0000040) | 2.18915917 |
| 95 | Hemiparesis (HP:0001269) | 2.16497934 |
| 96 | Thickened helices (HP:0000391) | 2.12529343 |
| 97 | Cerebral inclusion bodies (HP:0100314) | 2.11453715 |
| 98 | Vaginal atresia (HP:0000148) | 2.10871889 |
| 99 | Genital tract atresia (HP:0001827) | 2.10373187 |
| 100 | Status epilepticus (HP:0002133) | 2.08861696 |
| 101 | Impaired smooth pursuit (HP:0007772) | 2.08372951 |
| 102 | Pancreatic cysts (HP:0001737) | 2.08157333 |
| 103 | Pancreatic fibrosis (HP:0100732) | 2.07150629 |
| 104 | Generalized myoclonic seizures (HP:0002123) | 2.06549362 |
| 105 | Cholecystitis (HP:0001082) | 2.06397258 |
| 106 | Abnormal gallbladder physiology (HP:0012438) | 2.06397258 |
| 107 | Menstrual irregularities (HP:0000858) | 2.05222330 |
| 108 | Abnormal EKG (HP:0003115) | 2.04195832 |
| 109 | Symptomatic seizures (HP:0011145) | 2.03302998 |
| 110 | Psychosis (HP:0000709) | 2.02970184 |
| 111 | Diminished movement (HP:0002374) | 2.02437924 |
| 112 | Fetal akinesia sequence (HP:0001989) | 2.01377015 |
| 113 | Absent/shortened dynein arms (HP:0200106) | 2.01376559 |
| 114 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.01376559 |
| 115 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.99641316 |
| 116 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.99641316 |
| 117 | Prominent metopic ridge (HP:0005487) | 1.99461337 |
| 118 | Akinesia (HP:0002304) | 1.99356287 |
| 119 | Congenital sensorineural hearing impairment (HP:0008527) | 1.99081065 |
| 120 | Dysmetric saccades (HP:0000641) | 1.97879004 |
| 121 | Poor coordination (HP:0002370) | 1.97706066 |
| 122 | Global brain atrophy (HP:0002283) | 1.97110668 |
| 123 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.96602488 |
| 124 | Abnormality of alanine metabolism (HP:0010916) | 1.96602488 |
| 125 | Hyperalaninemia (HP:0003348) | 1.96602488 |
| 126 | Syncope (HP:0001279) | 1.96405777 |
| 127 | Delusions (HP:0000746) | 1.96181553 |
| 128 | Absent speech (HP:0001344) | 1.93977169 |
| 129 | Abnormality of vitamin metabolism (HP:0100508) | 1.93188251 |
| 130 | True hermaphroditism (HP:0010459) | 1.92783509 |
| 131 | Abnormal drinking behavior (HP:0030082) | 1.92420592 |
| 132 | Polydipsia (HP:0001959) | 1.92420592 |
| 133 | Methylmalonic aciduria (HP:0012120) | 1.90766262 |
| 134 | Ankle clonus (HP:0011448) | 1.90621150 |
| 135 | Action tremor (HP:0002345) | 1.90191521 |
| 136 | Bradykinesia (HP:0002067) | 1.88346966 |
| 137 | Mutism (HP:0002300) | 1.87674993 |
| 138 | Esotropia (HP:0000565) | 1.87216804 |
| 139 | Scanning speech (HP:0002168) | 1.86142585 |
| 140 | Abnormality of the metopic suture (HP:0005556) | 1.85786875 |
| 141 | Prolonged QT interval (HP:0001657) | 1.85647263 |
| 142 | Leukodystrophy (HP:0002415) | 1.83270738 |
| 143 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.81739401 |
| 144 | Abnormality of the lower motor neuron (HP:0002366) | 1.81199299 |
| 145 | Postural instability (HP:0002172) | 1.80728226 |
| 146 | Incomplete penetrance (HP:0003829) | 1.80536852 |
| 147 | Spastic gait (HP:0002064) | 1.80407746 |
| 148 | Hypokinesia (HP:0002375) | 1.80073185 |
| 149 | Abnormality of salivation (HP:0100755) | 1.79728611 |
| 150 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.79031099 |
| 151 | Abnormal pupillary function (HP:0007686) | 1.78638852 |
| 152 | Hepatic necrosis (HP:0002605) | 1.76351513 |
| 153 | Furrowed tongue (HP:0000221) | 1.76187186 |
| 154 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.76005750 |
| 155 | Emotional lability (HP:0000712) | 1.74453386 |
| 156 | Abnormality of the renal medulla (HP:0100957) | 1.73413075 |
| 157 | Termporal pattern (HP:0011008) | 1.72839072 |
| 158 | Sensory axonal neuropathy (HP:0003390) | 1.72302669 |
| 159 | Lipid accumulation in hepatocytes (HP:0006561) | 1.71794686 |
| 160 | Restlessness (HP:0000711) | 1.71448312 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.72131919 |
| 2 | CASK | 5.08216140 |
| 3 | NTRK3 | 4.19026640 |
| 4 | EPHA4 | 4.09104996 |
| 5 | MAP3K12 | 4.05252780 |
| 6 | FGFR2 | 3.54222077 |
| 7 | MAP3K4 | 3.53084705 |
| 8 | MAP2K7 | 3.27618342 |
| 9 | RIPK4 | 3.17398243 |
| 10 | CDK19 | 2.70132762 |
| 11 | DAPK2 | 2.57639447 |
| 12 | MAP2K4 | 2.47142617 |
| 13 | PHKG1 | 2.47040074 |
| 14 | PHKG2 | 2.47040074 |
| 15 | PLK2 | 2.34398599 |
| 16 | MAP3K9 | 2.32763482 |
| 17 | PINK1 | 2.28499821 |
| 18 | MINK1 | 2.10584364 |
| 19 | NME1 | 2.09862098 |
| 20 | DAPK1 | 2.09307450 |
| 21 | WNK3 | 2.00952370 |
| 22 | MARK1 | 1.99258825 |
| 23 | PNCK | 1.99103568 |
| 24 | MAP3K2 | 1.90830651 |
| 25 | BMPR2 | 1.80474727 |
| 26 | STK38L | 1.75958541 |
| 27 | GRK1 | 1.73356164 |
| 28 | GRK5 | 1.59644864 |
| 29 | OXSR1 | 1.48605299 |
| 30 | NTRK2 | 1.45987609 |
| 31 | CAMKK2 | 1.43875408 |
| 32 | CCNB1 | 1.43221682 |
| 33 | AKT3 | 1.40103885 |
| 34 | MAP3K13 | 1.39135860 |
| 35 | ARAF | 1.38798956 |
| 36 | KSR1 | 1.25902096 |
| 37 | FGFR3 | 1.24141401 |
| 38 | PAK6 | 1.24098095 |
| 39 | PRKCG | 1.22401826 |
| 40 | BRAF | 1.22071791 |
| 41 | MAP4K2 | 1.20775907 |
| 42 | PTK2B | 1.18604255 |
| 43 | CDK5 | 1.18363090 |
| 44 | CSNK1G1 | 1.17337904 |
| 45 | MAP2K6 | 1.11697164 |
| 46 | INSRR | 1.10171396 |
| 47 | CAMK2A | 1.07168396 |
| 48 | TSSK6 | 1.07018422 |
| 49 | PRPF4B | 1.05319755 |
| 50 | NLK | 1.04416161 |
| 51 | MST4 | 1.01182851 |
| 52 | NTRK1 | 0.99680599 |
| 53 | KSR2 | 0.99580292 |
| 54 | PASK | 0.96376809 |
| 55 | GRK7 | 0.94647523 |
| 56 | WNK4 | 0.91587805 |
| 57 | TNIK | 0.89479157 |
| 58 | CSNK1G3 | 0.84410486 |
| 59 | CAMKK1 | 0.83882329 |
| 60 | CDK18 | 0.83206971 |
| 61 | FES | 0.82957519 |
| 62 | CAMK2B | 0.82936176 |
| 63 | DAPK3 | 0.82311646 |
| 64 | FGR | 0.81825864 |
| 65 | ERBB3 | 0.79338273 |
| 66 | BCR | 0.78710715 |
| 67 | MAPK13 | 0.77938321 |
| 68 | CDK15 | 0.77882445 |
| 69 | CDK14 | 0.77828043 |
| 70 | MYLK | 0.70292202 |
| 71 | DYRK2 | 0.69258466 |
| 72 | ADRBK1 | 0.68285189 |
| 73 | TRPM7 | 0.68228063 |
| 74 | CDK11A | 0.67827421 |
| 75 | BRD4 | 0.67816430 |
| 76 | PRKCE | 0.67216577 |
| 77 | SGK494 | 0.66643914 |
| 78 | SGK223 | 0.66643914 |
| 79 | CAMK1 | 0.65660241 |
| 80 | LIMK1 | 0.63936417 |
| 81 | GRK6 | 0.61968563 |
| 82 | SIK2 | 0.61788173 |
| 83 | ROCK2 | 0.61757557 |
| 84 | STK38 | 0.60083943 |
| 85 | WNK1 | 0.58524550 |
| 86 | TNK2 | 0.58404861 |
| 87 | ADRBK2 | 0.58340902 |
| 88 | UHMK1 | 0.57896569 |
| 89 | STK24 | 0.57743764 |
| 90 | DYRK1A | 0.57617831 |
| 91 | PRKAA1 | 0.56734840 |
| 92 | CSNK1A1L | 0.56494191 |
| 93 | CDK8 | 0.56364354 |
| 94 | ACVR1B | 0.53768867 |
| 95 | MKNK2 | 0.51927026 |
| 96 | BMPR1B | 0.51529056 |
| 97 | MAP3K7 | 0.50344798 |
| 98 | PDK3 | 0.50344497 |
| 99 | PDK4 | 0.50344497 |
| 100 | STK3 | 0.50201045 |
| 101 | MAP3K6 | 0.50009865 |
| 102 | PRKACB | 0.48700379 |
| 103 | PRKG1 | 0.48426450 |
| 104 | TAOK1 | 0.48023186 |
| 105 | RPS6KA4 | 0.47656514 |
| 106 | SGK2 | 0.47434554 |
| 107 | FER | 0.46735735 |
| 108 | SIK3 | 0.46444778 |
| 109 | CAMK2D | 0.45644324 |
| 110 | SGK1 | 0.45635470 |
| 111 | RAF1 | 0.44424495 |
| 112 | CSNK1G2 | 0.44273746 |
| 113 | TYRO3 | 0.44082405 |
| 114 | CSNK1A1 | 0.43458576 |
| 115 | PRKCI | 0.42879293 |
| 116 | CAMK2G | 0.42259754 |
| 117 | LATS2 | 0.39501888 |
| 118 | ZAK | 0.39278078 |
| 119 | CSNK1E | 0.39218092 |
| 120 | CSNK1D | 0.39158120 |
| 121 | PDPK1 | 0.38685487 |
| 122 | PRKACA | 0.38656879 |
| 123 | HIPK2 | 0.38304822 |
| 124 | CAMK4 | 0.37628354 |
| 125 | MAPK12 | 0.35940755 |
| 126 | PKN1 | 0.34828913 |
| 127 | PRKAA2 | 0.34799806 |
| 128 | STK39 | 0.33390123 |
| 129 | STK11 | 0.31691592 |
| 130 | PRKCZ | 0.31340262 |
| 131 | PDK1 | 0.31122025 |
| 132 | MAP2K1 | 0.30646183 |
| 133 | PRKCA | 0.30560942 |
| 134 | CAMK1G | 0.29999987 |
| 135 | RPS6KA3 | 0.28828007 |
| 136 | PAK3 | 0.28585993 |
| 137 | NEK1 | 0.28279855 |
| 138 | CDK3 | 0.27451556 |
| 139 | MOS | 0.26579524 |
| 140 | DDR2 | 0.26372139 |
| 141 | CDC42BPA | 0.25985261 |
| 142 | MAP3K1 | 0.25762490 |
| 143 | FYN | 0.24835581 |
| 144 | PRKCB | 0.24411876 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.72302407 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 4.43305540 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.71650881 |
| 4 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.31195118 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.17484194 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.89903443 |
| 7 | Long-term potentiation_Homo sapiens_hsa04720 | 2.60592789 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.56285031 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.55653919 |
| 10 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.53773124 |
| 11 | Circadian entrainment_Homo sapiens_hsa04713 | 2.50320106 |
| 12 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.40531335 |
| 13 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.32552031 |
| 14 | Parkinsons disease_Homo sapiens_hsa05012 | 2.30878737 |
| 15 | Olfactory transduction_Homo sapiens_hsa04740 | 2.25405856 |
| 16 | Alzheimers disease_Homo sapiens_hsa05010 | 2.18060354 |
| 17 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.05666645 |
| 18 | Salivary secretion_Homo sapiens_hsa04970 | 2.02171829 |
| 19 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.96829753 |
| 20 | Taste transduction_Homo sapiens_hsa04742 | 1.95872666 |
| 21 | Renin secretion_Homo sapiens_hsa04924 | 1.93358653 |
| 22 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.92976199 |
| 23 | Protein export_Homo sapiens_hsa03060 | 1.91949806 |
| 24 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.83567033 |
| 25 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.76949686 |
| 26 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.76464493 |
| 27 | Long-term depression_Homo sapiens_hsa04730 | 1.69061711 |
| 28 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.68871937 |
| 29 | Insulin secretion_Homo sapiens_hsa04911 | 1.64140968 |
| 30 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.63471360 |
| 31 | Huntingtons disease_Homo sapiens_hsa05016 | 1.61287260 |
| 32 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.58048499 |
| 33 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.51738466 |
| 34 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.51244306 |
| 35 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.46553770 |
| 36 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.45209083 |
| 37 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.36447682 |
| 38 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.34756296 |
| 39 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.30988929 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.29918099 |
| 41 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.23256912 |
| 42 | Cocaine addiction_Homo sapiens_hsa05030 | 1.22249747 |
| 43 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.19007246 |
| 44 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.14871464 |
| 45 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.14794248 |
| 46 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.14723270 |
| 47 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.12229330 |
| 48 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.11476265 |
| 49 | Gap junction_Homo sapiens_hsa04540 | 1.11166851 |
| 50 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.10890318 |
| 51 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.10164627 |
| 52 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.08643995 |
| 53 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.06373032 |
| 54 | Phototransduction_Homo sapiens_hsa04744 | 1.04644999 |
| 55 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.00158590 |
| 56 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.97836939 |
| 57 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.94794417 |
| 58 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.91670674 |
| 59 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.91111028 |
| 60 | Basal transcription factors_Homo sapiens_hsa03022 | 0.90184413 |
| 61 | Axon guidance_Homo sapiens_hsa04360 | 0.89162103 |
| 62 | Melanogenesis_Homo sapiens_hsa04916 | 0.87608195 |
| 63 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.87065867 |
| 64 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.86308615 |
| 65 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.84974361 |
| 66 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.80592164 |
| 67 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.78740693 |
| 68 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.78246327 |
| 69 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.77890461 |
| 70 | Mineral absorption_Homo sapiens_hsa04978 | 0.76527501 |
| 71 | Peroxisome_Homo sapiens_hsa04146 | 0.75866512 |
| 72 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.74622074 |
| 73 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.73767138 |
| 74 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.70554822 |
| 75 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.70070611 |
| 76 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.66488790 |
| 77 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.63692655 |
| 78 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.63136606 |
| 79 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.62884713 |
| 80 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.62829211 |
| 81 | Glioma_Homo sapiens_hsa05214 | 0.62236406 |
| 82 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.60529773 |
| 83 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60286777 |
| 84 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.58133389 |
| 85 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.57628754 |
| 86 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.57402396 |
| 87 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.55885977 |
| 88 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.55816903 |
| 89 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.54384330 |
| 90 | ABC transporters_Homo sapiens_hsa02010 | 0.54039785 |
| 91 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.53787361 |
| 92 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.52488082 |
| 93 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.50111159 |
| 94 | Phagosome_Homo sapiens_hsa04145 | 0.50099680 |
| 95 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.48790016 |
| 96 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.47780295 |
| 97 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.46869646 |
| 98 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.46862685 |
| 99 | Metabolic pathways_Homo sapiens_hsa01100 | 0.42233296 |
| 100 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.39804934 |
| 101 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.39712901 |
| 102 | Alcoholism_Homo sapiens_hsa05034 | 0.38863253 |
| 103 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.38580902 |
| 104 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.38268798 |
| 105 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37414054 |
| 106 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37328423 |
| 107 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.37204660 |
| 108 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.36686048 |
| 109 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.36480197 |
| 110 | Retinol metabolism_Homo sapiens_hsa00830 | 0.35879950 |
| 111 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.35474456 |
| 112 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.34469960 |
| 113 | Circadian rhythm_Homo sapiens_hsa04710 | 0.32530108 |
| 114 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.32212192 |
| 115 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.29685337 |
| 116 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.29676098 |
| 117 | Prion diseases_Homo sapiens_hsa05020 | 0.29641209 |
| 118 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.28887492 |
| 119 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.28748878 |
| 120 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.25443755 |
| 121 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.24767046 |
| 122 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.24620827 |
| 123 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.23927389 |
| 124 | Melanoma_Homo sapiens_hsa05218 | 0.22938292 |
| 125 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.22846598 |
| 126 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.20475229 |
| 127 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.18689209 |
| 128 | Bile secretion_Homo sapiens_hsa04976 | 0.15261513 |
| 129 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.13111252 |
| 130 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.12886768 |
| 131 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.12510815 |
| 132 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.12340812 |
| 133 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.12023063 |
| 134 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.11195806 |
| 135 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.10199255 |

